Marino Stram & Associates’s CryoPort CYRX Stock Holding History

Marino Stram & Associates’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-720	Closed	-$9K	–	187
2019 Q1	$9K	Hold	720	–	–	0.01%	312
2018 Q4	$8K	Hold	720	–	–	0.01%	298
2018 Q3	$9K	Hold	720	–	–	0.01%	310
2018 Q2	$11K	Hold	720	–	–	0.01%	289
2018 Q1	$6K	Buy	+720	New	+$6.36K	0.01%	358

Other funds holding CYRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Marino Stram & Associates's CYRX Position: Q2 2019 in Review

Marino Stram & Associates sold out of CryoPort (CYRX) in Q2 2019, closing a stake of 720 shares — an estimated $9K sold.

Marino Stram & Associates first reported a position in CYRX in Q1 2018 and held it in 5 quarters. The position peaked at $11K in Q2 2018. 102 funds tracked by Wall St. Rank hold CYRX as of Q2 2019.

Marino Stram & Associates reported no remaining CryoPort position as of Q2 2019 after selling out during the quarter.
Marino Stram & Associates sold 720 CryoPort shares in Q2 2019, an estimated $9K.
Marino Stram & Associates first reported a position in CryoPort in Q1 2018 and held it in 5 quarters.
Marino Stram & Associates's CryoPort position peaked at $11K in Q2 2018.
102 funds tracked by Wall St. Rank held CryoPort as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.